The FDA has approved the ReShape Integrated Dual Balloon System (ReShape Medical) and the Orbera Intragastric Balloon System (Apollo Endosurgery) for up to 6 months of use in adults with a BMI of 30-40 who have not been able to maintain weight loss with a weight loss program and, for ReShape, who have at least one obesity-related comorbidity. Both devices have been available in the European Union and elsewhere for years (20 years for Orbera). Three other devices, the LAP-Band, the Realize adjustable gastric band, and the Maestro Rechargeable System, are FDA-approved for long-term treatment of obesity.1

THE DEVICES — The ReShape Dual Balloon device consists of two silicone balloons attached to a central silicone shaft. The balloons are placed in the stomach endoscopically and inflated with a ... more      

Would you like to read the rest of this article?  Gain access below.